N
Nagalingeswaran Kumarasamy
Researcher at University of North Carolina at Chapel Hill
Publications - 28
Citations - 7365
Nagalingeswaran Kumarasamy is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 5, co-authored 5 publications receiving 6620 citations.
Papers
More filters
Journal ArticleDOI
Recent Trends in Adult and Pediatric Antiretroviral Therapy Monitoring and Failure
David C Boettiger,V. T. An,Nagalingeswaran Kumarasamy,Iskandar Azwa,Tavitiya Sudjaritruk,Khanh Huu Truong,Anchalee Avihingsanon,Jeremy D. Ross,Azar Kariminia +8 more
TL;DR: Although viral failure in the Asian cohort now comprises a larger portion of ART failure than in prior years, the diagnostic characteristics of immune and clinical failure, and recommendations on their management, remain important inclusions for regional ART guidelines.
Journal ArticleDOI
Patterns and prognosis of holding regimens for people living with HIV in Asian countries
Jung Ho Kim,Awachana Jiamsakul,Sasisopin Kiertiburanakul,Bui Vu Huy,Suwimon Khusuwan,Nagalingeswaran Kumarasamy,Oon Tek Ng,Penh Sun Ly,Man Po Lee,Yu Jiun Chan,Yasmin Mohamed Gani,Iskandar Azwa,Anchalee Avihingsanon,Tuti Parwati Merati,Sanjay Puri,Romanee Chaiwarith,Fujie Zhang,Junko Tanuma,Cuong Duy Do,Rossana Ditangco,Evy Yunihastuti,Jeremy D. Ross,Jun Yong Choi +22 more
TL;DR: Considering the high mortality rate of PLWH with holding regimen, efforts to extend accessibility to additional antiretroviral options are needed in Asian countries.
Posted ContentDOI
Mucosal immunity and antibody anergy in COVID-exposed Covishield vaccinees
Priya Kannian,Pasuvaraj Mahanathi,A. Gracemary,Nagalingeswaran Kumarasamy,Stephen Challacombe +4 more
TL;DR: The findings suggest that first dose acts as an antibody boost, while second dose induces antibody anergy in the previously COVID exposed group, which raises concerns over their durability in subsequent virus exposures.